The DNA Cancer Risk Screening Test is a preventive genetic analysis designed to evaluate your inherited risk for a range of hereditary cancers. This test examines specific genes known to significantly increase susceptibility to cancers such as breast, ovarian, prostate, thyroid, colon, and pancreatic cancer.

Using advanced genomic technology, the test detects variations in high-impact genes like BRCA1, BRCA2, TP53, MLH1, MSH2, CHEK2, APC, PTEN, and KRAS, among others. These genes are closely associated with hereditary cancer syndromes such as Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome, which dramatically increase cancer risk across generations.

The analysis looks for both pathogenic and likely pathogenic variants, classifying whether they are homozygous or heterozygous, and whether their inheritance is dominant or recessive. A positive finding may indicate that you or your family members carry a genetic mutation that increases cancer risk and may benefit from targeted surveillance, early detection, or lifestyle modification strategies.

For individuals already diagnosed with cancer, these results can also influence the choice of therapy, extent of surgery, and monitoring plans. For healthy individuals, it provides a risk overview that helps them stay one step ahead through personalized medical advice and preventive screenings like colonoscopies or mammograms, sometimes at earlier ages or more frequent intervals.

It’s important to note that this is a screening test, not a diagnostic one. It does not detect all possible cancer-related mutations, and a negative result does not rule out all risk. Additionally, this panel covers only a selected set of clinically significant variants, and deeper testing may be required if you have a strong family history or early-onset cancers.

As part of responsible care, individuals are encouraged to consult with a genetic counselor or healthcare professional to interpret the results accurately and decide on next steps. Any positive findings should ideally be confirmed through clinical-grade testing (e.g., Sanger sequencing) before making medical decisions.

Ultimately, this test gives you critical insight into your genetic risk so you can take proactive control of your health. By understanding your predisposition early, you can create a personalized prevention plan, protect your well-being, and support informed decisions for both you and your family.